Dale Q Rice Investment Management Ltd Reduces Stock Holdings in iShares Biotechnology ETF $IBB

Dale Q Rice Investment Management Ltd trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 56.7% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 2,508 shares of the financial services provider’s stock after selling 3,285 shares during the period. Dale Q Rice Investment Management Ltd’s holdings in iShares Biotechnology ETF were worth $329,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Moors & Cabot Inc. grew its stake in iShares Biotechnology ETF by 2.0% during the 1st quarter. Moors & Cabot Inc. now owns 29,053 shares of the financial services provider’s stock valued at $3,716,000 after purchasing an additional 558 shares during the last quarter. IFP Advisors Inc grew its stake in iShares Biotechnology ETF by 23.9% during the 1st quarter. IFP Advisors Inc now owns 19,849 shares of the financial services provider’s stock valued at $2,539,000 after purchasing an additional 3,831 shares during the last quarter. N.E.W. Advisory Services LLC purchased a new stake in iShares Biotechnology ETF during the 1st quarter valued at about $45,000. Kingswood Wealth Advisors LLC grew its stake in iShares Biotechnology ETF by 81.2% during the 1st quarter. Kingswood Wealth Advisors LLC now owns 4,532 shares of the financial services provider’s stock valued at $570,000 after purchasing an additional 2,031 shares during the last quarter. Finally, John G Ullman & Associates Inc. purchased a new stake in iShares Biotechnology ETF during the 1st quarter valued at about $230,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 0.5%

iShares Biotechnology ETF stock opened at $154.19 on Friday. The business’s 50-day simple moving average is $142.93 and its two-hundred day simple moving average is $131.41. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $156.36.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.0828 per share. This represents a $0.33 annualized dividend and a yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.